‘Not for sale’: Australia defends PBS against US big pharma GPs welcome plans to make PBS-listed medicines even cheaper, but it comes as US pharma giants take aim at the scheme.
PBS co-payment freeze rolls out In 2025, the maximum patient cost for all PBS medicines will remain the same as in 2024 instead of increasing with indexation.
GP feedback sought to shape the future of MBS The DoHAC is reviewing common MBS time-tiered items for primary care, and the RACGP wants members’ input to ensure a strong future.
Challenges facing newly arrived doctors in spotlight An Australian Medical Council survey has highlighted ongoing barriers for IMGs as the impact of Government reforms kick in.
Medicare watchdog repayments soar by $10m The PSR recouped $32 million from negotiated agreements and determinations last year, often through doctors’ ‘lack of clinical input and poor record keeping’.
In Practice: RACGP seeking new dermatology Chair Nominations are open for a new Specific Interests Dermatology Chair, for RACGP Fellows or members registered with AHPRA as specialist GPs.
RACGP calls for regulation overhaul amid growing complexity It says significant changes are needed to complaints handling, accreditation and governance, as a review works to ‘streamline and harmonise’.
Review shows success of eating disorder MBS items While the RACGP says shared care must be in place, the review is a welcome ‘observation of reforms’ and a ‘deeper dig’.
‘Visionary’ review suggests quicker approval of new medicines New subsidised medication approvals would be streamlined and access made easier for vulnerable populations, under a new health technology plan.
New National Sustainable Asthma Care Roadmap released Each year, Australian inhalers cause the same greenhouse impact as 350,000 cars, but experts have found a way to help both patients and the climate.